FDA clears AngioScore catheter

05/2/2008 | American City Business Journals

The FDA has granted AngioScore approval to market its AngioSculpt PTA catheter, which can be used for balloon dilatation of lesions in various arteries and to treat certain obstructive lesions. The clearance allows the company "to address several of the largest and fastest growing segments of the peripheral artery disease market in the U.S.," CEO Thomas R. Trotter said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA